68Ga-PSMA-11 trials for Prostate cancer

All 68Ga-PSMA-11 trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying 68Ga-PSMA-11 for Prostate cancer

• 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
  NCT05324332 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
  NCT07209878 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• PSMA PET Combined With MRI for the Detection of PCa
  NCT07052214 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 18 locations
• Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
  NCT04886986 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: Male · 2 locations
• Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
  NCT04946370 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 4 locations

Common questions

How many trials study 68Ga-PSMA-11 for Prostate cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.